Making every breath easier, for everyone.
Clinically proven asthma inhaler sleeve that cuts activation force by 75%, making inhalers up to 300% easier to squeeze and improving treatment adherence.
Meet the Easy Squeezy
Transforms your inhaler from leading brands like Asthavent® and Ventolin® into an Easy Squeezy® device, dramatically reducing the effort needed to dispense medicine for children, seniors, and anyone with limited grip.
The super power for inhalers
THE EASY SQUEEZY® STORY
SOUTH AFRICA HAS THE 5TH HIGHEST RATE OF ASTHMA DEATHS IN THE WORLD, MANY CAUSED NOT BY THE LACK OF MEDICINE, BUT BY HOW HARD IT IS TO USE AN INHALER CORRECTLY.
OVER 50% OF PATIENTS USE INHALERS INCORRECTLY, MEANING TREATMENT DOESN’T REACH THEIR LUNGS WHEN IT’S NEEDED MOST.
THAT’S WHERE EASY SQUEEZY® COMES IN.
A CLINICALLY PROVEN ASTHMA INHALER SLEEVE THAT FITS OVER LEADING INHALERS, MAKING THEM UP TO 300% EASIER TO ACTIVATE AND CUTTING THE REQUIRED ACTIVATION FORCE BY 75%.
WE ARE SAHPRA APPROVED, CE MARKED, AND ISO 13485 CERTIFIED - THE GLOBAL GOLD STANDARD FOR MEDICAL DEVICES.
TESTED FOR DURABILITY, GOOD FOR OVER 24,000 PUFFS GUARANTEED.
IMAGINE DROPPING OFF YOUR CHILD AT SCHOOL, KNOWING THEY CAN USE THEIR INHALER CONFIDENTLY ON THEIR OWN.
IMAGINE YOUR ELDERLY PARENT NO LONGER NEEDING YOUR HELP TO TAKE THEIR MEDICATION.
NOW IMAGINE THE PEACE OF MIND THAT BRINGS TO EVERY FAMILY MEMBER.
IT’S LIKE HAVING YOUR GUARDIAN WITH YOU, IN EVERY BREATH.
WE’RE PROUD TO BE FIRST TO MARKET GLOBALLY, SOLVING A PROBLEM THAT WOULD OTHERWISE REQUIRE COSTLY INHALER REDESIGNS AND RECERTIFICATIONS.
EASY SQUEEZY® DESIGNED FOR REAL PEOPLE, BUILT TO SAVE LIVES, AND MADE TO LAST.
WITH PEACE OF MIND. WITH CONFIDENCE.
YOUR SUPERPOWER FOR INHALERS.
Independant clinical studies have been completed
Increased patient satisfaction and ease of use reported across the board.
Phase 1 was published in the South African Medical Journal (SAMJ), showing significant increases in the Childhood Asthma Control Test (C-ACT) scores.
26% improvement in the childhood asthma control and adherence.
Phase 2 was published in the Journal of Allergy and Clinical Immunology (JACI), showing stellar performance on the Pediatric Asthma Quality of Life (PAQL) questionnaires. Improvement in lung function was observed using spirometer.
AFSA Master Class to raise awareness with hundreds of doctors
We have presented our results to hundreds of doctors in a AFSA master class. Doctors in South Africa and around the world are excited about the product.
Collaborative successes.
Our impactful partnerships that have driven our success.
Partner with us.
We’re a medical device company born out of UCT, endorsed by AFSA, and redefining how the world breathes.
